NEWS & EVENTS

News: Variantyx Launches Its WGS-Based Prenatal Test for High-Risk Pregnancies, Enters Women’s Health Market

Variantyx, a leader in high complexity hereditary disease testing, announced today that it will launch its Genomic Unity® Prenatal Analysis test at the Society for Maternal Fetal Medicine’s 41st Annual Pregnancy Meeting being held virtually January 25-30 …

Read More

Events: SMFM’s 41st Annual Pregnancy Meeting

Join us at the Society for Maternal Fetal Medicine’s virtual conference!

Read More

Article: Ethics in Whole Genome Sequencing

The use of whole-genome sequencing (WGS) in diagnostic testing brings up the topic of secondary findings or incidental findings for many clinicians. Secondary findings are variants associated with a condition other than the one for which the patient is tested …

Read More

Variantyx Inc.

1671 Worcester Road, Suite 300
Framingham MA 01701 USA

Phone: +1 617-209-2090

  • This site is protected by reCAPTCHA and the Google Privacy and Terms of Service apply

Please do not submit Protected Health Information (PHI) through this email address.

If you need to submit Protected Health Information (PHI), please call us at 617-209-2090 and we will work with you to submit the information through an alternate mechanism.

Otherwise, please continue: